Search Results
Research
This document covers executive actions taken by the Administration of President Donald Trump directed at China. Executive actions include (1) executive orders from the president and (2) other significant measures taken by federal agencies relating to U.S.-China policy.
Research
The novel coronavirus (COVID-19) pandemic has brought unprecedented attention to challenges in China’s domestic healthcare system. The report reviews those challenges and examines the efforts of China’s policymakers to address them.
Hearings
The hearing examines the Chinese government's use of capital markets to advance its technology and defense capabilities and evaluate the risks of U.S. investors' capital being leveraged for such ends. The first panel examines the evolving role of the state in China's capital markets, including the Chinese Communist Party's involvement in corporate governance. The second panel reviews China's financial opening and U.S. and foreign investor participation in China's capital markets. The third panel assesses U.S. national security risks posed by investment in Chinese companies. The fourth panel evaluates U.S. legal authority and current restrictions on outbound investment to China's capital markets.
Research
The U.S.-China Economic and Security Review Commission invites submission of proposals to provide a concise, one-time unclassified report on China’s industrial overcapacity. Proposals must be submitted by March 26, 2021 at 5:30 pm ET.